U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. Center for Biologics Evaluation and Research (CBER) 2022 Science Symposium Meeting Agenda
  1. News & Events

Center for Biologics Evaluation and Research (CBER) 2022 Science Symposium Meeting Agenda

Tuesday, September 20, 2022

Keynote Speaker: Dr. Paul Offit, Children's Hospital of Philadelphia

Session 1: Advanced Manufacturing and Analytics

Dr. Stacy Springs, Massachusetts Institute of Technology
Dr. Kyung Sung, Office of Tissues & Advanced Therapies, CBER
Dr. Robert Daniels, Office of Vaccines Research & Review, CBER

Session 2: Advances in Computational Science Supporting Biologics’ Evaluation 

Dr. Sharon-Lise Normand, Harvard School of Public Health
Dr. Konstantinos Karagiannis, Office of Biostatistics and Pharmacovigilance, CBER

Wednesday, September 21, 2022

Session 3: Biomarker Discovery

Dr. Lisa Butterfield, University of California San Francisco
Dr. Krishnakumar Devadas, Office of Blood Research & Review, CBER
Dr. Tod Merkel, Office of Vaccines Research & Review, CBER 

Session 4: Immune Responses to Vaccination

Dr. JoAnne Flynn, University of Pittsburgh
Dr. Surender Khurana, Office of Vaccines Research & Review, CBER

Historical Perspective

Dr. David Asher, Former Laboratory Chief and Principal Investigator, CBER  

Thursday, September 22, 2022  

Session 5: Gene Therapy, Including Gene Editing

Dr. David R. Liu, Harvard University
Zhaohui Ye, Office of Tissues & Advanced Therapies, CBER

Session 6: Emerging and Re-emerging Diseases

Michael Diamond, Washington University
Tony Wang, Office of Vaccines Research & Review, CBER
David McGivern, Office of Blood Research & Review, CBER

Back to Top